FDA nasal BA/BE
FDA nasal BA/BE guidance frames product-quality evidence for locally acting nasal aerosols and nasal sprays.
AlignedStandards
Plume geometryFDA nasal BA/BEUSP <601>
This standards cluster covers spray pattern and plume geometry for imaging-based nasal spray and aerosol performance studies.
Use this cluster when development, comparison, or regulatory documentation depends on spray shape, plume angle, image analysis, actuation setup, and report evidence.
Standard roster
Individual standards in this cluster
FDA nasal BA/BE guidance and USP <601> provide the citation context; ARE Labs maps applicable endpoints to imaging geometry, actuation controls, analysis outputs, and reviewable records.
USP <601>
USP <601> supplies compendial performance-quality context for inhalation and nasal aerosols, sprays, and powders.
AccreditedPurpose & when to use
Spray pattern and plume geometry studies describe how a spray leaves the device. These studies use controlled actuation, imaging planes, lighting, timing, and image analysis. This standards cluster helps teams assess how FDA nasal BA/BE guidance and USP <601> relate to nasal and inhalation product studies, and when engineered sprays need a separately defined protocol:
- Nasal programs use FDA nasal BA/BE guidance when spray pattern, plume angle, and replicate image evidence support a local-action comparison.
- Inhalation or nasal drug products use USP <601> when actuation setup and performance-quality documentation must connect with delivered spray evidence.
- Device-development teams use FDA and USP anchors to compare actuators, formulation changes, spray distances, and image-analysis outputs.
- Engineered spray teams use fit-for-purpose imaging protocols, with FDA or USP context limited to endpoints that match the product and study question.
When a decision depends on image-based spray evidence across replicate actuations, confirm the product and endpoint before choosing FDA or USP context. Keep the imaging setup and analysis records available for review.
Applicable to
Built around imaging-based spray decisions
The cluster applies when spray performance depends on actuator positioning, plume development, image capture timing, analysis geometry, and reportable shape metrics across drug delivery or engineered spray formats.
Standards in this group
What each citation controls
FDA nasal BA/BE draft guidance provides study context for locally acting nasal aerosols and sprays. USP <601> provides compendial performance-quality context where the product and endpoint fit. The protocol identifies the applicable measurements, imaging configuration, replicate plan, analysis settings, and limitations; engineered sprays require their own rationale rather than automatic assignment to either citation.
FDA
AlignedFDA nasal BA/BE
Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action
FDA nasal BA/BE guidance frames product-quality evidence for locally acting nasal aerosols and nasal sprays. ARE Labs uses it to plan spray pattern, plume geometry, replicate strategy, image settings, method validation context, and report documentation for development or comparison studies.
FDA official draft guidance page verified 2026-10-06; page lists April 2003 and draft status.
USP
AccreditedUSP <601>
Inhalation and Nasal Drug Products: Aerosols, Sprays, and Powders - Performance Quality Tests
USP <601> supplies compendial performance-quality context for inhalation and nasal aerosols, sprays, and powders. For this cluster, ARE Labs uses it to connect actuation setup, product performance testing, spray characterization, and documentation expectations where the chapter applies.
USP official preview page verified 2026-10-06; effective date not publicly confirmed from preview.
Accredited where held, aligned where followed
ARE Labs separates formal accreditation from protocol alignment. USP <601> may be cited as accredited where the scope applies; FDA nasal BA/BE draft guidance is followed by protocol without an accreditation claim. Imaging endpoints and any adaptations are identified in the study plan.
- FDA nasal BA/BEAlignedDraft FDA guidance translated into protocol and report controls.
- USP <601>AccreditedAccredited performance-quality frame where scope applies.
Operational chain
How ARE Labs turns the standards into a study
Spray pattern and plume geometry work depends on geometry, timing, illumination, actuation, and analysis settings. ARE Labs maps applicable FDA and USP references into a protocol that explains the measurement basis and any product-specific adaptations.
01
Configuration
Define the imaging setup
FDA nasal BA/BE objectives drive image plane, actuation distance, lighting, trigger timing, replicate count, and spray-pattern endpoint choices.
Protocol setup02
Actuation
Control the device event
USP <601> context informs actuator positioning, product handling, dose-event documentation, and performance-quality links for nasal or inhalation products.
Run record03
Analysis
Lock image processing choices
FDA study files identify thresholding, background correction, scale verification, exclusions, plume angle, width, area, ovality, or circularity outputs.
Analysis workbook04
Rationale
Document protocol adaptations
When the spray format or endpoint differs from FDA or USP applications, ARE Labs records the imaging rationale, protocol adaptations, and interpretation limits.
Rationale log05
Reporting
Tie images to reviewable evidence
Reports connect FDA or USP study purpose, setup records, representative images, replicate variability, deviations, and limitations to the final interpretation.
Review-ready reportData quality, QA/QC & documentation
Reviewing an imaging study requires records of both image capture and analysis. For studies framed by FDA and USP references, ARE Labs documents fixture alignment, scale checks, timing controls, raw-image retention, processing settings, deviations, and QA review. These records let reviewers interpret the results alongside the setup that produced them.
Record the imaging geometry
FDA nasal BA/BE files link actuation distance, image plane, lighting, camera position, trigger timing, and replicate count to study objectives.
Preserve scale and timing checks
USP <601> performance context is paired with scale verification, timing checks, fixture notes, and product-handling records where applicable.
Retain raw and processed images
FDA spray pattern outputs retain raw images, processed files, thresholds, background correction, calculations, representative frames, and replicate summaries.
Record imaging rationale
FDA or USP study records identify why the imaging geometry, analysis settings, and protocol adaptations fit the product and selected endpoint.
Separate scope from alignment
ISO 17025 review language distinguishes accredited USP <601> scope from aligned FDA draft guidance and separately defined imaging protocols.
Why ARE Labs
ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.
Reviewed byJamie Balarashti - Weston Schaper
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported
Common questions
These questions help nasal, inhalation, and engineered-spray teams decide whether FDA nasal BA/BE draft guidance, USP <601>, or a fit-for-purpose protocol is appropriate for a spray pattern or plume geometry study. The answers cover product applicability, imaging evidence, protocol adaptations, and the records needed before study planning and reporting begin.
Q. Which citation controls my study?
A. For locally acting nasal aerosols and sprays, FDA nasal BA/BE guidance is usually the starting point. USP <601> applies where compendial performance-quality testing fits the product and endpoint.
Q. How are engineered spray studies scoped?
A. Engineered sprays need a protocol matched to the device and the measurement question. ARE Labs defines actuation, imaging geometry, timing, replicate strategy, and analysis settings. We also record whether any FDA or USP context applies to the selected endpoint.
Q. What does aligned mean here?
A. Aligned means ARE Labs follows the citation or guidance through the study protocol where applicable. ARE Labs does not claim formal accreditation unless the citation is within its accredited scope.
Q. What data does the report include?
A. Reports can include setup geometry, actuation records, representative images, plume angle, width, spray area, ovality or circularity, replicate statistics, processing settings, deviations, and method notes.
Q. Can the method be adapted?
A. Yes. When no standard fits the device exactly, ARE Labs documents the fit-for-purpose setup, the rationale, and the analysis limits. We also explain how the selected FDA or USP anchor was used.
Related services & devices
Related services & devices
Service
Spray Pattern & Plume Geometry
Primary service route for plume angle, spray pattern, imaging, and replicate analysis.Read more ->ServiceHigh-Speed Imaging & Velocimetry
Adds transient plume capture and velocity-related methods for time-resolved spray questions.Read more ->ServiceParticle Size Distribution (PSD) Testing
Pairs spray-shape evidence with droplet or aerosol particle-size characterization.Read more ->ServiceDose Uniformity & Emitted Dose
Connects image-based spray behavior to emitted-dose or delivered-dose evidence.Read more ->ServiceBreathing Simulation
Supports inhalation or nasal setups where spray performance depends on use conditions.Read more ->DevicesNasal Drug Spray Devices
Primary device route for local-action nasal sprays and nasal aerosol evidence.Read more ->DevicesMetered Dose Inhalers
Pressurized inhaler devices where actuation and plume behavior can affect performance.Read more ->DevicesPressurized Consumer Aerosols
Consumer aerosol formats where plume shape, timing, and spray spread may matter.Read more ->DevicesPump Spray Products
Pump spray formats that use pattern, width, and distribution evidence for development.Read more ->DevicesOral Spray Devices
Oral sprays where actuator behavior and plume geometry can support device decisions.Read more ->Related clusters
Related standards clusters
Spray pattern and plume geometry often sit beside particle sizing, delivered-dose, nebulizer, and optical measurement clusters. These routes keep neighboring standards separate from the imaging-specific controls on this page.
Standards